Massachusetts Financial Services CO Charles River Laboratories International, Inc. Transaction History

Massachusetts Financial Services CO

$320 Billion
Q3 2024

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 09, 2022	SELL	$182.44 - $250.54 $108 Million - $148 Million	-590,305 Reduced 68.61%	270,130 $53.2 Million
Q2 2022 Aug 09, 2022	SELL	$204.13 - $302.4 $57.5 Million - $85.2 Million	-281,787 Reduced 24.67%	860,435 $184 Million
Q1 2022 May 11, 2022	SELL	$255.51 - $362.11 $38.3 Million - $54.3 Million	-149,893 Reduced 11.6%	1,142,222 $324 Million
Q4 2021 Feb 10, 2022	SELL	$351.38 - $448.68 $22.9 Million - $29.2 Million	-65,131 Reduced 4.8%	1,292,115 $487 Million
Q3 2021 Nov 10, 2021	SELL	$372.64 - $458.3 $30.2 Million - $37.2 Million	-81,163 Reduced 5.64%	1,357,246 $560 Million
Q2 2021 Aug 13, 2021	BUY	$294.17 - $371.65 $17.6 Million - $22.3 Million	59,970 Added 4.35%	1,438,409 $532 Million
Q1 2021 May 13, 2021	BUY	$249.67 - $299.48 $1.67 Million - $2 Million	6,689 Added 0.49%	1,378,439 $400 Million
Q4 2020 Feb 12, 2021	BUY	$222.0 - $252.62 $23.1 Million - $26.2 Million	103,869 Added 8.19%	1,371,750 $343 Million
Q3 2020 Nov 12, 2020	BUY	$175.56 - $226.45 $71.9 Million - $92.7 Million	409,339 Added 47.68%	1,267,881 $287 Million
Q2 2020 Aug 11, 2020	BUY	$118.84 - $189.72 $32 Million - $51.2 Million	269,611 Added 45.78%	858,542 $150 Million
Q1 2020 May 14, 2020	BUY	$98.9 - $178.34 $34.9 Million - $62.9 Million	352,637 Added 149.24%	588,931 $74.3 Million
Q4 2019 Feb 13, 2020	BUY	$126.05 - $152.76 $913,484 - $1.11 Million	7,247 Added 3.16%	236,294 $36.1 Million
Q3 2019 Nov 05, 2019	BUY	$125.07 - $143.67 $6.86 Million - $7.88 Million	54,841 Added 31.48%	229,047 $30.3 Million
Q2 2019 Aug 14, 2019	BUY	$123.4 - $148.55 $2 Million - $2.41 Million	16,211 Added 10.26%	174,206 $24.7 Million
Q1 2019 May 13, 2019	SELL	$104.82 - $146.73 $2.72 Million - $3.81 Million	-25,959 Reduced 14.11%	157,995 $22.9 Million
Q4 2018 Feb 08, 2019	SELL	$105.09 - $137.23 $6.83 Million - $8.91 Million	-64,957 Reduced 26.1%	183,954 $20.8 Million
Q3 2018 Oct 25, 2018	BUY	$112.11 - $134.54 $5.18 Million - $6.22 Million	46,195 Added 22.79%	248,911 $33.5 Million
Q2 2018 Jul 30, 2018	BUY	$102.37 - $117.25 $8.15 Million - $9.34 Million	79,619 Added 64.68%	202,716 $22.8 Million
Q1 2018 May 04, 2018	BUY	$98.19 - $115.2 $12.1 Million - $14.2 Million	123,097 New	123,097 $13.1 Million

Others Institutions Holding CRL

# of Institutions

691

Shares Held

51.6M

Call Options Held

259K

Put Options Held

463K

Vanguard Group Inc Valley Forge, PA

6.1M
Shares

$1 Billion
0.02% of portfolio
Black Rock Inc. New York, NY

5.09M
Shares

$838 Million
0.02% of portfolio
Wellington Management Group LLP Boston, MA

3.74M
Shares

$616 Million
0.13% of portfolio
State Street Corp Boston, MA

2.13M
Shares

$351 Million
0.02% of portfolio
Kayne Anderson Rudnick Investment Management LLC Los Angeles, CA

1.94M
Shares

$320 Million
0.87% of portfolio

View Full List

About CHARLES RIVER LABORATORIES INTERNATIONAL, INC.

Ticker CRL
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 50,863,300
Market Cap $8.38B
Description
Charles River Laboratories International, Inc., a non-clinical contract research organization, provides drug discovery, non-clinical development, and safety testing services in the United States, Europe, Canada, the Asia Pacific, and internationally. It operates through three segments: Research Models and Services (RMS), Discovery and Safety Ass...

More about CRL

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Massachusetts Financial Services CO , based on Form 13F filings with the SEC.

News

Stay updated on Massachusetts Financial Services CO with notifications on news.

Account